Hangzhou Cobridge Pharmaceutical Co., Ltd.
Hangzhou Cobridge Pharmaceutical Co., Ltd.
Main Products:TAK438, (3aR,4S,7R,7aS)-2-[(1R,2R)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl]hexahydro-1H-4,7-methanoisoindole-1,3-dione hydrochloride, Aminomethylbenzoic acid,
View moreAbout Us
Contact Supplier
Hot Products
+ more![China (3aR,4S,7R,7aS)-2-[(1R,2R)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl]hexahydro-1H-4,7-methanoisoindole-1,3-dione hydrochloride - China Supplier](https://ui-chn.toocle.com/images/noimg.png "China (3aR,4S,7R,7aS)-2-[(1R,2R)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl]hexahydro-1H-4,7-methanoisoindole-1,3-dione hydrochloride - China Supplier")
(3aR,4S,7R,7aS)-2-[(1R,2R)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl]hexahydro-1H-4,7-methanoisoindole-1,3-dione hydrochloride
Chemicals/Chemical Intermediates/Intermediate CompoundsNegotiable
Send Inquiry
(1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Chemicals/Chemical Intermediates/Intermediate CompoundsNegotiable
Send Inquiry
GLP-1 receptor agonist 1
Chemicals/Chemical Intermediates/Intermediate CompoundsNegotiable
Send Inquiry
1,2,4-Triazine-6-carbonitrile,2-[3,5-dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-
Chemicals/Chemical Intermediates/Intermediate CompoundsNegotiable
Send Inquiry
5-(4-HEXYLOXY-[1,2,5]THIADIAZOL-3-YL)-1-METHYL-1,2,3,6-TETRAHYDRO-PYRIDINE
Chemicals/Heterocyclic Compounds/PyridineNegotiable
Send Inquiry
4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-2-sulfonamide
Chemicals/Chemical Intermediates/Intermediate CompoundsNegotiable
Send Inquiry
((3aS,5R,6S,6aS)-6-hydroxy-2,2-diMethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(Morpholino)Methanone
Chemicals/Chemical Intermediates/Intermediate CompoundsNegotiable
Send InquiryCompany Profile
+ more
Cobridge Pharmaceutical is a leading manufacturer of APIs and intermediates with 20 years of experience in the industry. We are a high tech enterprise with a R&D center based in Hangzhou, Zhejiang, China.
Most of the products are self-developed. We hold national and international patents for many products. Our factory is fully equipped, including more than three hundred 500-5000L glass-lined and stainless steel reactors, with a total capacity of 600m3. We have industrial production for complex operating reactions and procedures, including: butyllithium reaction, Grignard reaction, hydrogenation reaction, low temperature reaction (-80°C), high pressure reaction (1-5Mpa), high vacuum distillation (=0.5mmHg), etc.
Cobridge is also a contract development and manufacturing organization (CDMO). We take pride in enabling our global clients to optimize drug development and manufacturing. When developing the world's leading drugs, Cobridge has established a complete quality assurance and quality control system according to GMP standards. We have a detection system, including Agilent HPLC, GC, UV, etc. We have an experienced quality management team, and we have various API production workshops compliant with GMP.
Cobridge values environmental protection, safety and sanitation. We insist on safety first, clean production, and humanity. We are continuously improving employee's salary, welfare, working and living environment.
With the business philosophy "Innovation, Characteristics, Quality", Cobridge continues to provide high quality products, competitive prices and the best service to our customers. We sincerely hope to establish strategic business relationships around the world.
Cobridge - your reliable and responsible partner.
